Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS People In Brief

Executive Summary

NYC Health Commissioner Frieden heads to CDC: President Obama appoints Thomas R. Frieden as the next director of the Centers for Disease Control and Prevention. He is the second top Obama health official to have served as New York City health commissioner, a position Frieden has held since 2002. Prior to that, FDA Commissioner-designate Margaret Hamburg held the post. An infectious disease specialist, the new CDC director worked at that agency from 1990 to 2002 and worked with Hamburg in the effort to stop the spread of drug-resistant tuberculosis in New York City. Their experience working together on a disease outbreak may be a bonus as both Frieden and Hamburg will likely find swine flu still on their agendas as they take office. Like a number of Obama appointees, Frieden has led smoking-reduction and cancer screening initiatives. The post does not require Senate confirmation; Frieden is expected to be on the job in June

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051069

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel